Simplex Trading’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-217
Closed -$518K 11100
2021
Q1
$518K Buy
+217
New +$4.03K ﹤0.01% 3326
2020
Q3
Sell
-299
Closed -$439K 8880
2020
Q2
$439K Sell
299
-198
-40% -$2.01K ﹤0.01% 3074
2020
Q1
$204K Buy
+497
New +$2.33K ﹤0.01% 3574
2019
Q4
Sell
-76
Closed -$46K 8295
2019
Q3
$46K Hold
76
﹤0.01% 5104
2019
Q2
$49K Sell
76
-29
-28% -$204 ﹤0.01% 4884
2019
Q1
$74K Buy
+105
New +$691 ﹤0.01% 4654
2016
Q2
Sell
-17
Closed -$4K 6708
2016
Q1
$4K Hold
17
﹤0.01% 4344
2015
Q4
$1K Buy
+17
New +$131 ﹤0.01% 5107
2015
Q3
Sell
-2
Closed -$1K 6465
2015
Q2
$1K Buy
+2
New +$20 ﹤0.01% 4890

Simplex Trading's GNMK Position: Q2 2021 in Review

Simplex Trading sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 3,834 shares — an estimated $91K sold.

Simplex Trading first reported a position in GNMK in Q2 2015 and held it in 16 quarters. The position peaked at $220K in Q1 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Simplex Trading reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Simplex Trading sold 3,834 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $91K.
  • Simplex Trading first reported a position in GenMark Diagnostics, Inc in Q2 2015 and held it in 16 quarters.
  • Simplex Trading's GenMark Diagnostics, Inc position peaked at $220K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.